Jon E. Angell

Array ( [id] => 7657384 [patent_doc_number] => 20110306653 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-12-15 [patent_title] => 'STABILIZATION METHOD OF FUNCTIONAL NUCLEIC ACID' [patent_app_type] => utility [patent_app_number] => 13/107175 [patent_app_country] => US [patent_app_date] => 2011-05-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 29 [patent_figures_cnt] => 29 [patent_no_of_words] => 21779 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0306/20110306653.pdf [firstpage_image] =>[orig_patent_app_number] => 13107175 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7719795 [patent_doc_number] => 20120009130 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-01-12 [patent_title] => 'Viral Therapy and Prophylaxis Using Nanotechnology Delivery Techniques' [patent_app_type] => utility [patent_app_number] => 13/102808 [patent_app_country] => US [patent_app_date] => 2011-05-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 16703 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0009/20120009130.pdf [firstpage_image] =>[orig_patent_app_number] => 13102808 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8479505 [patent_doc_number] => 20120278913 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-11-01 [patent_title] => 'Ribozyme Effector Gene in Dengue Fever Transmission and Disease Control' [patent_app_type] => utility [patent_app_number] => 13/096649 [patent_app_country] => US [patent_app_date] => 2011-04-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 12647 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13096649 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8577731 [patent_doc_number] => 08343941 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-01-01 [patent_title] => 'Compositions and methods for gene silencing' [patent_app_type] => utility [patent_app_number] => 13/082865 [patent_app_country] => US [patent_app_date] => 2011-04-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 42 [patent_figures_cnt] => 41 [patent_no_of_words] => 31567 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 85 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13082865 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8442383 [patent_doc_number] => 20120258998 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-10-11 [patent_title] => 'Fusion genes in gastrointestinal cancer' [patent_app_type] => utility [patent_app_number] => 13/066087 [patent_app_country] => US [patent_app_date] => 2011-04-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 25 [patent_no_of_words] => 24634 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13066087 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8708655 [patent_doc_number] => 20130065944 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-03-14 [patent_title] => 'REVERSE MICELLE SYSTEM COMPRISING NUCLEIC ACIDS AND USE THEREOF' [patent_app_type] => utility [patent_app_number] => 13/636452 [patent_app_country] => US [patent_app_date] => 2011-03-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 12373 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13636452 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8733937 [patent_doc_number] => 20130079505 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-03-28 [patent_title] => 'BIVALENT ANTISENSE OLIGONUCLEOTIDES' [patent_app_type] => utility [patent_app_number] => 13/636459 [patent_app_country] => US [patent_app_date] => 2011-03-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 14764 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13636459 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7501970 [patent_doc_number] => 20110263680 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-10-27 [patent_title] => 'REDUCED SIZE SELF-DELIVERING RNAI COMPOUNDS' [patent_app_type] => utility [patent_app_number] => 13/069780 [patent_app_country] => US [patent_app_date] => 2011-03-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 92 [patent_figures_cnt] => 92 [patent_no_of_words] => 79414 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0263/20110263680.pdf [firstpage_image] =>[orig_patent_app_number] => 13069780 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8270364 [patent_doc_number] => 08211868 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-07-03 [patent_title] => 'Paramyxovirus vector encoding angiogenesis gene and use thereof' [patent_app_type] => utility [patent_app_number] => 13/049011 [patent_app_country] => US [patent_app_date] => 2011-03-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 22767 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 49 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13049011 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6015683 [patent_doc_number] => 20110223607 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-09-15 [patent_title] => 'CIRCULATING MICRORNA AS A MARKER FOR HEPATOCELLULAR CARCINOMA' [patent_app_type] => utility [patent_app_number] => 13/046187 [patent_app_country] => US [patent_app_date] => 2011-03-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 15847 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0223/20110223607.pdf [firstpage_image] =>[orig_patent_app_number] => 13046187 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9099830 [patent_doc_number] => 08563709 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-10-22 [patent_title] => 'Method for inhibiting function of micro-RNA' [patent_app_type] => utility [patent_app_number] => 13/039156 [patent_app_country] => US [patent_app_date] => 2011-03-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 36 [patent_figures_cnt] => 36 [patent_no_of_words] => 28884 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 96 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13039156 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5937707 [patent_doc_number] => 20110213011 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-09-01 [patent_title] => 'MODULATION OF SMAD3 EXPRESSION' [patent_app_type] => utility [patent_app_number] => 13/035772 [patent_app_country] => US [patent_app_date] => 2011-02-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 29747 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0213/20110213011.pdf [firstpage_image] =>[orig_patent_app_number] => 13035772 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8359698 [patent_doc_number] => 20120214860 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-08-23 [patent_title] => 'METHOD OF REGULATING THE EXPRESSION LEVEL OF SURVIVAL OF MOTOR NEURON 1 (SMN1) AND DETECTING ENZYME ACTIVITY OF UBIQUITIN CARBOXYL-TERMINAL HYDROLASE L1 (UCHL1)' [patent_app_type] => utility [patent_app_number] => 13/032846 [patent_app_country] => US [patent_app_date] => 2011-02-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 4415 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13032846 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8538051 [patent_doc_number] => 08313772 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-11-20 [patent_title] => 'Compositions for targeted delivery of siRNA' [patent_app_type] => utility [patent_app_number] => 13/032029 [patent_app_country] => US [patent_app_date] => 2011-02-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 6 [patent_no_of_words] => 24487 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13032029 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8707954 [patent_doc_number] => 20130065243 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-03-14 [patent_title] => 'METHOD FOR PRODUCING INDUCED PLURIPOTENT STEM CELLS' [patent_app_type] => utility [patent_app_number] => 13/579314 [patent_app_country] => US [patent_app_date] => 2011-02-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 10732 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13579314 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6164375 [patent_doc_number] => 20110160707 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-06-30 [patent_title] => 'COMPOSITIONS, DEVICES AND METHODS FOR TREATMENT OF HUNTINGTON\'S DISEASE THROUGH INTRACRANIAL DELIVERY OF SIRNA' [patent_app_type] => utility [patent_app_number] => 13/028638 [patent_app_country] => US [patent_app_date] => 2011-02-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 14227 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0160/20110160707.pdf [firstpage_image] =>[orig_patent_app_number] => 13028638 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7651949 [patent_doc_number] => 20110301218 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-12-08 [patent_title] => 'MODIFIED snRNAs FOR USE IN THERAPY' [patent_app_type] => utility [patent_app_number] => 13/025428 [patent_app_country] => US [patent_app_date] => 2011-02-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 17286 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0301/20110301218.pdf [firstpage_image] =>[orig_patent_app_number] => 13025428 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8637085 [patent_doc_number] => 20130028889 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-01-31 [patent_title] => 'DOSING REGIMENS FOR TREATING AND PREVENTING OCULAR DISORDERS USING C-RAF ANTISENSE' [patent_app_type] => utility [patent_app_number] => 13/577219 [patent_app_country] => US [patent_app_date] => 2011-02-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 21542 [patent_no_of_claims] => 45 [patent_no_of_ind_claims] => 26 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13577219 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10018572 [patent_doc_number] => 09061042 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-06-23 [patent_title] => 'Composition for suppressing expression of target gene' [patent_app_type] => utility [patent_app_number] => 13/017562 [patent_app_country] => US [patent_app_date] => 2011-01-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 7 [patent_no_of_words] => 23254 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 124 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13017562 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7696716 [patent_doc_number] => 20110229874 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-09-22 [patent_title] => 'COMPOSITIONS AND METHODS USEFUL FOR HCV INFECTION' [patent_app_type] => utility [patent_app_number] => 13/013758 [patent_app_country] => US [patent_app_date] => 2011-01-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 8074 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0229/20110229874.pdf [firstpage_image] =>[orig_patent_app_number] => 13013758 [rel_patent_id] =>[rel_patent_doc_number] =>)